Abstract
The present invention provides a method of treating, delaying the onset, delaying progression of, reducing the incidence of or reducing the severity of amyotrophic lateral sclerosis in a subject, the method comprising administering to a subject an agent, which interferes with IgG-A2BG2 expression, IgG-A2BG2 function or IgG-A2BG2 interaction with CD16 in said subject.
| Original language | English |
|---|---|
| Patent number | EP2788017 |
| IPC | A61P 25/ 28 A I |
| Priority date | 4/12/12 |
| State | Published - 15 Oct 2014 |